retatrutide obesity triple hormone receptor agonist Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more at our link in bio retatrutide obesity triple hormone receptor

Mild redness, slight swelling, or brief itching are common and typically harmless

High systolic blood pressure is closely tied to cardiovascular risk, especially as people get older

Early Response as Predictor Week 12 emerges as a critical assessment point in the data

In the UK, the regulatory pathway for new medicines requires the MHRA to assess comprehensive evidence of safety, efficacy, and quality before granting a marketing authorisation

If you use a breathing device, such as a CPAP machine, bring it on the day of your surgery

The Vial technique does require more attention than a pen device, especially for new patients